Oxazepam
Product Description
Osmopharm S.A.
-
Country/Region:Switzerland
-
On CPHI since:2015
Specifications
Osmopharm S.A.
-
Country/Region:Switzerland
-
On CPHI since:2015
More Products from Osmopharm S.A. (99)
-
Product Nifedipine + Atenolol
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nifedipine + atenolol. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Nitrofurantoin
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nitrofurantoin. It belongs to antibacteral category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Nitroglycerin
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nitroglycerin. It belongs to antianginal/ vasodiolator coronary category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Norphenephrine HCI
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes norphenephrine HCI. It is used for treatment of hipotensive states. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Nylidrin / Buphenine
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nylidrin / buphenine. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Omeprazolo
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes omeprazolo. It belongs to antiulcerative category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Oxeladine Citrate
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes oxeladine citrate. It belongs to antitussive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Pancreatine
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pancreatine. It belongs to digestive aid category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Paracetamol
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes paracetamol. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Pentaerythritol Tetranitrate (PETN)
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pentaerythritol tetranitrate (PETN). It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Pentoxifyline
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pentoxifyline. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Phentemine HCI
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phentemine HCI. It belongs to anorexic category. Bulk physical form: pellets, resinates, powder DC. Final dosage form: caps/tabs. Contact us for more information.
